PATENT CLAIM ANALYSIS

Application Number: 16044255
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-07
Patent Classification: ["514", "391000"]

Abstract:
This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.

Claim (Index 85):
The pharmaceutical composition according to  claim 83 , wherein the polymer is a polymer or two or more polymers selected from the group consisting of polyvinyl pyrrolidone, polyethyleneoxide, poly(vinyl pyrrolidone-co-vinyl acetate), polymethacrylates, polyoxyethylene alkyl ethers, polyoxyethylene castor oils, polycaprolactam, polylactic acid, polyglycolic acid, poly(lactic-glycolic) acid, lipids, cellulose, pullulan, dextran, maltodextrin, hyaluronic acid, polysialic acid, chondroitin sulfate, heparin, fucoidan, pentosan polysulfate, spirulan, hydroxypropyl methyl cellulose, hydroxypropyl cellulose, 10 carboxymethyl ethylcellulose, hydroxypropyl methylcellulose acetate succinate, cellulose acetate phthalate, cellulose acetate trimellitate, ethyl cellulose, cellulose acetate, cellulose butyrate, cellulose acetate butyrate, and dextran polymer derivative.

Metadata:
- Claim Count in Document: 55.0
- Percentile: 95.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13843224', '13494668', '11799447', '10459808', '13610350']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8096271130152487
- 35 USC 102 Novelty (BERT): 0.5030802796804809
- Combined Prediction Score: 0.7789724296817719
- Mean Citation Score: 260.50458
- Max Citation Score: 271.86276000000004
- Similarity Product: 219.2020479263449

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test